2-(4-Methylphenoxy)ethanol
Common Name: |
2-(4-Methylphenoxy)ethanol |
IUPAC Name: |
2-(4-methylphenoxy)ethanol |
Molecular Formula: |
C9H12O2 |
SMILES: |
CC1=CC=C(C=C1)OCCO |
Inchi: |
1S/C9H12O2/c1-8-2-4-9(5-3-8)11-7-6-10/h2-5,10H,6-7H2,1H3 |
Inchi Key: |
FFWXHQFJNOGDJE-UHFFFAOYSA-N |
Cas No: |
15149-10-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
152.19 |
Mass (g/mol) |
152.084 |
Molar Refractivity |
43.87 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
29.46 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
262.00 to 264.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.005 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.33 |
LogP |
1.366 |
iLOGP |
2.15 |
XLOGP3 |
1.45 |
WLOGP |
1.37 |
MLOGP |
1.53 |
ESOL Log S |
-1.90 |
ESOL Solubility (mg/ml) |
1.9 |
ESOL Solubility (mol/l) |
0.013 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.67 |
Ali Solubility (mg/ml) |
3.22 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.74 |
Silicos-IT Solubility (mg/ml) |
0.28 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.20 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.847 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.227 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |